ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 Genetic Test
At DNA Labs UAE, we offer the ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 Genetic Test. This test helps diagnose individuals with Alternating Hemiplegia of Childhood (AHC) type 2, a rare neurological disorder characterized by recurrent episodes of paralysis affecting one side of the body or the other.
Test Components
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on FTA Card for this test.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
This test is specifically designed for diagnosing neurological disorders.
Doctor
The test is performed under the supervision of a Neurologist.
Test Department
This test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2.
Test Details
Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that typically develops in early childhood. It is characterized by recurrent episodes of paralysis affecting one side of the body or the other. AHC is caused by mutations in the ATP1A3 gene, which provides instructions for making a protein essential for the proper functioning of nerve cells.
Our NGS genetic testing utilizes advanced technology to analyze multiple genes simultaneously. By conducting an NGS genetic test for the ATP1A3 gene, we can identify mutations associated with AHC type 2, which is a specific subtype of AHC.
If an individual is suspected of having AHC or has a family history of the disorder, they may be suitable candidates for NGS genetic testing. The results from this test can provide a definitive diagnosis and assist in guiding treatment and management strategies.
Test Name | ATP1A3 Gene Alternating hemiplegia of childhood type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ATP1A3 Gene Alternating hemiplegia of childhood type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A3 Gene Alternating hemiplegia of childhood type 2 |
Test Details | Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that typically develops in early childhood and is characterized by recurrent episodes of paralysis affecting one side of the body or the other. AHC is caused by mutations in the ATP1A3 gene, which provides instructions for making a protein that is essential for the proper functioning of nerve cells. NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the rapid and comprehensive analysis of multiple genes simultaneously. A NGS genetic test for the ATP1A3 gene can identify mutations that are associated with AHC type 2, which is a specific subtype of AHC. Individuals who are suspected of having AHC or who have a family history of the disorder may be candidates for NGS genetic testing. Results from the test can provide a definitive diagnosis and may help guide treatment and management strategies. |